Skip to content
10-Q

Quarterly Report

Anthera Pharmaceuticals Inc

0001214659-17-004902

← back to feed
Filed
Aug 9, 2017 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2017 · Jul 31, 2017 10.91M sh
Cash And Equivalents Q2 2017 · Jun 30, 2017 $11.15M
Cash And Equivalents Q2 2017 · Dec 31, 2016 $20.84M
Cash And Equivalents Q2 2017 · Jun 30, 2016 $28.5M
Cash And Equivalents Q2 2017 · Dec 31, 2015 $46.95M
Stockholders Equity Q2 2017 · Jun 30, 2017 $4.56M
Stockholders Equity Q2 2017 · Dec 31, 2016 $12.47M
Current Liabilities Q2 2017 · Jun 30, 2017 $4.25M
Current Liabilities Q2 2017 · Dec 31, 2016 $10.62M
Total Liabilities Q2 2017 · Jun 30, 2017 $9.95M
Total Liabilities Q2 2017 · Dec 31, 2016 $10.62M
Current Assets Q2 2017 · Jun 30, 2017 $13.95M
Current Assets Q2 2017 · Dec 31, 2016 $22.71M
Total Assets Q2 2017 · Jun 30, 2017 $14.51M
Total Assets Q2 2017 · Dec 31, 2016 $23.47M
Sga Expense Q2 2017 · Jun 30, 2017 $1.63M
Sga Expense Q2 2017 · Jun 30, 2017 $4.53M
Sga Expense Q2 2017 · Jun 30, 2016 $2.58M
Sga Expense Q2 2017 · Jun 30, 2016 $4.81M
Rd Expense Q2 2017 · Jun 30, 2017 $7.03M
Rd Expense Q2 2017 · Jun 30, 2017 $14.84M
Rd Expense Q2 2017 · Jun 30, 2016 $11.97M
Rd Expense Q2 2017 · Jun 30, 2016 $21.59M
Net Income Q2 2017 · Jun 30, 2017 $313K
Net Income Q2 2017 · Jun 30, 2017 −$10.89M
Net Income Q2 2017 · Jun 30, 2016 −$14.33M
Net Income Q2 2017 · Jun 30, 2016 −$26.06M
Operating Income Q2 2017 · Jun 30, 2017 −$8.66M
Operating Income Q2 2017 · Jun 30, 2017 −$19.26M
Operating Income Q2 2017 · Jun 30, 2016 −$14.28M
Operating Income Q2 2017 · Jun 30, 2016 −$26M
Capex Q2 2017 · Jun 30, 2016 $662K
Revenue Q2 2017 · Jun 30, 2016 $145K